A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Grifols Sa stock. As of the latest transaction made, Citadel Advisors LLC holds 184,200 shares of GRFS stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
184,200
Previous 29,000 535.17%
Holding current value
$1.29 Million
Previous $335,000 267.16%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$5.47 - $11.38 $957,064 - $1.99 Million
-174,966 Reduced 57.14%
131,226 $876,000
Q4 2023

Feb 14, 2024

BUY
$7.71 - $11.56 $2.02 Million - $3.03 Million
262,463 Added 600.2%
306,192 $3.54 Million
Q3 2023

Nov 14, 2023

BUY
$8.91 - $10.91 $84,030 - $102,892
9,431 Added 27.5%
43,729 $399,000
Q2 2023

Aug 14, 2023

BUY
$7.14 - $9.29 $186,810 - $243,063
26,164 Added 321.66%
34,298 $314,000
Q1 2023

May 15, 2023

SELL
$6.65 - $10.69 $1.78 Million - $2.86 Million
-267,785 Reduced 97.05%
8,134 $59,000
Q4 2022

Feb 14, 2023

SELL
$5.96 - $8.53 $5.3 Million - $7.59 Million
-889,501 Reduced 76.32%
275,919 $2.35 Million
Q3 2022

Nov 14, 2022

BUY
$5.95 - $14.3 $5.96 Million - $14.3 Million
1,000,998 Added 608.8%
1,165,420 $7.18 Million
Q2 2022

Aug 15, 2022

SELL
$10.6 - $13.28 $2.7 Million - $3.38 Million
-254,615 Reduced 60.76%
164,422 $1.95 Million
Q1 2022

May 16, 2022

BUY
$10.37 - $12.73 $36,460 - $44,758
3,516 Added 0.85%
419,037 $4.89 Million
Q4 2021

Feb 14, 2022

BUY
$10.21 - $15.27 $3.42 Million - $5.12 Million
335,141 Added 416.95%
415,521 $4.67 Million
Q3 2021

Nov 15, 2021

SELL
$14.07 - $17.3 $1.89 Million - $2.32 Million
-134,202 Reduced 62.54%
80,380 $1.17 Million
Q2 2021

Aug 16, 2021

BUY
$16.62 - $18.94 $778,464 - $887,130
46,839 Added 27.92%
214,582 $3.72 Million
Q1 2021

May 17, 2021

BUY
$15.15 - $19.78 $1.08 Million - $1.41 Million
71,516 Added 74.32%
167,743 $2.9 Million
Q4 2020

Feb 16, 2021

SELL
$16.86 - $19.67 $3.93 Million - $4.59 Million
-233,099 Reduced 70.78%
96,227 $1.77 Million
Q3 2020

Nov 16, 2020

BUY
$15.4 - $20.16 $3.18 Million - $4.16 Million
206,483 Added 168.09%
329,326 $5.71 Million
Q2 2020

Aug 14, 2020

BUY
$18.24 - $21.45 $2.24 Million - $2.63 Million
122,843 New
122,843 $2.24 Million
Q1 2020

May 15, 2020

SELL
$16.28 - $25.63 $573,365 - $902,662
-35,219 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$19.57 - $23.52 $28.7 Million - $34.5 Million
-1,466,862 Reduced 97.66%
35,219 $821,000
Q3 2019

Nov 14, 2019

BUY
$19.85 - $22.76 $15.7 Million - $18 Million
791,621 Added 111.42%
1,502,081 $30.1 Million
Q2 2019

Aug 14, 2019

BUY
$17.59 - $21.1 $3.68 Million - $4.42 Million
209,278 Added 41.76%
710,460 $15 Million
Q1 2019

May 15, 2019

BUY
$18.01 - $20.11 $6.53 Million - $7.29 Million
362,451 Added 261.26%
501,182 $0
Q4 2018

Feb 14, 2019

BUY
$17.44 - $21.53 $1.77 Million - $2.19 Million
101,775 Added 275.4%
138,731 $2.55 Million
Q2 2018

Aug 10, 2018

BUY
$20.16 - $24.68 $745,032 - $912,074
36,956 New
36,956 $0
Q1 2018

May 11, 2018

SELL
$20.31 - $24.95 $1.81 Million - $2.23 Million
-89,273 Closed
0 $0
Q4 2017

Feb 09, 2018

SELL
$20.99 - $23.89 $2.2 Million - $2.5 Million
-104,654 Reduced 53.97%
89,273 $2.05 Million
Q3 2017

Nov 09, 2017

BUY
$20.07 - $21.89 $3.89 Million - $4.25 Million
193,927
193,927 $4.25 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $4.75B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.